UnivTrevesV1, PubMed, Corpus, bibRecord, 000927

[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].

Identifieur interne : 000927 ( PubMed/Corpus ); précédent : 000926; suivant : 000928

[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].

Auteurs : T. Schneider ; R. Strupp ; E. Kühnen ; C. Jochem ; W H Boesken

Source :

Der Internist [ 0020-9554 ] ; 1997.

RBID : pubmed:9378623

English descriptors

KwdEn :
- Abdominal Abscess (diagnosis), Abdominal Abscess (drug therapy), Abdominal Abscess (immunology), Adult, Cyclophosphamide (administration & dosage), Cyclophosphamide (adverse effects), Diagnosis, Differential, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Fever of Unknown Origin (etiology), Humans, Imipenem (therapeutic use), Immunosuppressive Agents (administration & dosage), Immunosuppressive Agents (adverse effects), Liver Abscess (diagnosis), Liver Abscess (drug therapy), Liver Abscess (immunology), Nocardia Infections (diagnosis), Nocardia Infections (drug therapy), Nocardia Infections (immunology), Nocardia asteroides (drug effects), Opportunistic Infections (diagnosis), Opportunistic Infections (drug therapy), Opportunistic Infections (immunology), Prednisolone (administration & dosage), Prednisolone (adverse effects), Recurrence, Splenic Diseases (diagnosis), Splenic Diseases (drug therapy), Splenic Diseases (immunology), Takayasu Arteritis (drug therapy), Takayasu Arteritis (immunology), Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use).
MESH :
- chemical , administration & dosage : Cyclophosphamide, Immunosuppressive Agents, Prednisolone.
- chemical , adverse effects : Cyclophosphamide, Immunosuppressive Agents, Prednisolone.
- diagnosis : Abdominal Abscess, Liver Abscess, Nocardia Infections, Opportunistic Infections, Splenic Diseases.
- drug effects : Nocardia asteroides.
- drug therapy : Abdominal Abscess, Liver Abscess, Nocardia Infections, Opportunistic Infections, Splenic Diseases, Takayasu Arteritis.
- etiology : Fever of Unknown Origin.
- immunology : Abdominal Abscess, Liver Abscess, Nocardia Infections, Opportunistic Infections, Splenic Diseases, Takayasu Arteritis.
- chemical , therapeutic use : Imipenem, Trimethoprim, Sulfamethoxazole Drug Combination.
- Adult, Diagnosis, Differential, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Recurrence.

PubMed: 9378623

Links to Exploration step

pubmed:9378623

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].</title>
<author><name sortKey="Schneider, T" sort="Schneider, T" uniqKey="Schneider T" first="T" last="Schneider">T. Schneider</name>
<affiliation><nlm:affiliation>II. Medizinische Abteilung, Krankenhaus der Barmherzigen Brüder, Trier.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Strupp, R" sort="Strupp, R" uniqKey="Strupp R" first="R" last="Strupp">R. Strupp</name>
</author>
<author><name sortKey="Kuhnen, E" sort="Kuhnen, E" uniqKey="Kuhnen E" first="E" last="Kühnen">E. Kühnen</name>
</author>
<author><name sortKey="Jochem, C" sort="Jochem, C" uniqKey="Jochem C" first="C" last="Jochem">C. Jochem</name>
</author>
<author><name sortKey="Boesken, W H" sort="Boesken, W H" uniqKey="Boesken W" first="W H" last="Boesken">W H Boesken</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9378623</idno>
<idno type="pmid">9378623</idno>
<idno type="wicri:Area/PubMed/Corpus">000927</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000927</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].</title>
<author><name sortKey="Schneider, T" sort="Schneider, T" uniqKey="Schneider T" first="T" last="Schneider">T. Schneider</name>
<affiliation><nlm:affiliation>II. Medizinische Abteilung, Krankenhaus der Barmherzigen Brüder, Trier.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Strupp, R" sort="Strupp, R" uniqKey="Strupp R" first="R" last="Strupp">R. Strupp</name>
</author>
<author><name sortKey="Kuhnen, E" sort="Kuhnen, E" uniqKey="Kuhnen E" first="E" last="Kühnen">E. Kühnen</name>
</author>
<author><name sortKey="Jochem, C" sort="Jochem, C" uniqKey="Jochem C" first="C" last="Jochem">C. Jochem</name>
</author>
<author><name sortKey="Boesken, W H" sort="Boesken, W H" uniqKey="Boesken W" first="W H" last="Boesken">W H Boesken</name>
</author>
</analytic>
<series><title level="j">Der Internist</title>
<idno type="ISSN">0020-9554</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abdominal Abscess (diagnosis)</term>
<term>Abdominal Abscess (drug therapy)</term>
<term>Abdominal Abscess (immunology)</term>
<term>Adult</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Cyclophosphamide (adverse effects)</term>
<term>Diagnosis, Differential</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Fever of Unknown Origin (etiology)</term>
<term>Humans</term>
<term>Imipenem (therapeutic use)</term>
<term>Immunosuppressive Agents (administration & dosage)</term>
<term>Immunosuppressive Agents (adverse effects)</term>
<term>Liver Abscess (diagnosis)</term>
<term>Liver Abscess (drug therapy)</term>
<term>Liver Abscess (immunology)</term>
<term>Nocardia Infections (diagnosis)</term>
<term>Nocardia Infections (drug therapy)</term>
<term>Nocardia Infections (immunology)</term>
<term>Nocardia asteroides (drug effects)</term>
<term>Opportunistic Infections (diagnosis)</term>
<term>Opportunistic Infections (drug therapy)</term>
<term>Opportunistic Infections (immunology)</term>
<term>Prednisolone (administration & dosage)</term>
<term>Prednisolone (adverse effects)</term>
<term>Recurrence</term>
<term>Splenic Diseases (diagnosis)</term>
<term>Splenic Diseases (drug therapy)</term>
<term>Splenic Diseases (immunology)</term>
<term>Takayasu Arteritis (drug therapy)</term>
<term>Takayasu Arteritis (immunology)</term>
<term>Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cyclophosphamide</term>
<term>Immunosuppressive Agents</term>
<term>Prednisolone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Cyclophosphamide</term>
<term>Immunosuppressive Agents</term>
<term>Prednisolone</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Abdominal Abscess</term>
<term>Liver Abscess</term>
<term>Nocardia Infections</term>
<term>Opportunistic Infections</term>
<term>Splenic Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Nocardia asteroides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Abdominal Abscess</term>
<term>Liver Abscess</term>
<term>Nocardia Infections</term>
<term>Opportunistic Infections</term>
<term>Splenic Diseases</term>
<term>Takayasu Arteritis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Fever of Unknown Origin</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Abdominal Abscess</term>
<term>Liver Abscess</term>
<term>Nocardia Infections</term>
<term>Opportunistic Infections</term>
<term>Splenic Diseases</term>
<term>Takayasu Arteritis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Imipenem</term>
<term>Trimethoprim, Sulfamethoxazole Drug Combination</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Diagnosis, Differential</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Recurrence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9378623</PMID>
<DateCreated><Year>1997</Year>
<Month>10</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0020-9554</ISSN>
<JournalIssue CitedMedium="Print"><Volume>38</Volume>
<Issue>8</Issue>
<PubDate><Year>1997</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Der Internist</Title>
<ISOAbbreviation>Internist (Berl)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].</ArticleTitle>
<Pagination><MedlinePgn>770-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schneider</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>II. Medizinische Abteilung, Krankenhaus der Barmherzigen Brüder, Trier.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Strupp</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kühnen</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jochem</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Boesken</LastName>
<ForeName>W H</ForeName>
<Initials>WH</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Rezidivierendes Fieber bei einer Patientin unter immunsuppressiver Therapie einer Takayasu-Arteriitis.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Internist (Berl)</MedlineTA>
<NlmUniqueID>0264620</NlmUniqueID>
<ISSNLinking>0020-9554</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>71OTZ9ZE0A</RegistryNumber>
<NameOfSubstance UI="D015378">Imipenem</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8064-90-2</RegistryNumber>
<NameOfSubstance UI="D015662">Trimethoprim, Sulfamethoxazole Drug Combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8N3DW7272P</RegistryNumber>
<NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber>
<NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018784" MajorTopicYN="N">Abdominal Abscess</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005335" MajorTopicYN="N">Fever of Unknown Origin</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015378" MajorTopicYN="N">Imipenem</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008100" MajorTopicYN="N">Liver Abscess</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009617" MajorTopicYN="N">Nocardia Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009616" MajorTopicYN="Y">Nocardia asteroides</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009894" MajorTopicYN="N">Opportunistic Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013158" MajorTopicYN="N">Splenic Diseases</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013625" MajorTopicYN="N">Takayasu Arteritis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015662" MajorTopicYN="N">Trimethoprim, Sulfamethoxazole Drug Combination</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1998</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1997</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">9378623</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000927 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000927 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Rhénanie
   |area=    UnivTrevesV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:9378623
   |texte=   [Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:9378623" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a UnivTrevesV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Jul 22 16:29:01 2017. Site generation: Wed Feb 28 14:55:37 2024

	Serveur d'exploration sur l'Université de Trèves
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'Université de Trèves

[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].

[Recurrent fever in a patient treated with immunosuppressive therapy for Takayasu arteritis].

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki